Hayato Nakagawa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Epithelial Mesenchymal Transition

Liver Metastases

Top Venues

Scientific reports

Hepatology (Baltimore, Md.)

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hayato Nakagawa, Aifu Lin
The translation of oncogenic mRNAs regulated by pseudouridylation: A new player in HCC. Hepatology (Baltimore, Md.) (2024)
Naoto Fujiwara, Hayato Nakagawa
Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease. Cancer science (2023)
Yasuyuki Tamai, Naoto Fujiwara, Takamitsu Tanaka, Hiroyuki Sakurai, Hayato Nakagawa
Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma. Cancers 15 (20) (2023)
Tomoharu Yamada, Naoto Fujiwara, Naoto Kubota, Yuki Matsushita, Takuma Nakatsuka, Shigeyuki Kurosaki, Tatsuya Minami, Ryosuke Tateishi, Akihiko Ichida, Junichi Arita, Kiyoshi Hasegawa, Kazuhiko Koike, Mitsuhiro Fujishiro, Hayato Nakagawa
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma. Hepatology communications 7 (8) (2023)
Yasuhiko Hamada, Kyosuke Tanaka, Masaki Katsurahara, Noriyuki Horiki, Yuhei Umeda, Yohei Ikenoyama, Hiroki Yukimoto, Masahiko Tameda, Junya Tsuboi, Reiko Yamada, Misaki Nakamura, Hayato Nakagawa
Propensity-score matched analysis to evaluate efficacy of endoscopic submucosal dissection for superficial esophageal cancer in gastrectomized patients. Scientific reports 12 (1) (2022)
Naoto Fujiwara, Naoto Kubota, Emilie Crouchet, Bhuvaneswari Koneru, Cesia A Marquez, Arun K Jajoriya, Gayatri Panda, Tongqi Qian, Shijia Zhu, Nicolas Goossens, Xiaochen Wang, Shuang Liang, Zhenyu Zhong, Christopher Song, Bachir A Taouli, Myron E Schwartz, Maria Isabel Fiel, Amit G Singal, Jorge A Marrero, Austin J Fobar, Neehar D Parikh, Indu Raman, Quan-Zhen Li, Masataka Taguri, Atsushi Ono, Hiroshi Aikata, Takashi Nakahara, Hayato Nakagawa, Yuki Matsushita, Ryosuke Tateishi, Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo-Ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F Baumert, Yujin Hoshida
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease. Science translational medicine 14 (650) (2022)
Takuma Nakatsuka, Hayato Nakagawa, Yuki Hayata, Taijiro Wake, Tomoharu Yamada, Mizuki Nishibatake Kinoshita, Ryo Nakagomi, Masaya Sato, Tatsuya Minami, Koji Uchino, Kenichiro Enooku, Yotaro Kudo, Yasuo Tanaka, Takahiro Kishikawa, Motoyuki Otsuka, Ryosuke Tateishi, Kazuhiko Koike
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma. Journal of gastroenterology 56 (5) (2021)
Yuki Matsushita, Hayato Nakagawa, Kazuhiko Koike
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat. Cancers 13 (3) (2021)